Effective Antitumor Immunity Can be Triggered by Targeting VISTA in Combination with a TLR3-specific Adjuvant

Title
Effective Antitumor Immunity Can be Triggered by Targeting VISTA in Combination with a TLR3-specific Adjuvant
Authors
Keywords
-
Journal
Cancer Immunology Research
Volume -, Issue -, Pages -
Publisher
American Association for Cancer Research (AACR)
Online
2023-10-18
DOI
10.1158/2326-6066.cir-23-0117

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More